Clinical Trials · NCT01560403

A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021

Name: A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Teduglutide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Shire
Enrollment: 14
Start date: May 2012
Locations: 5 sites, United States
Primary endpoint: Summary of Treatment-emergent Adverse Events

View Teduglutide compound reference